507515 Stock Overview
Engages in the manufacture and sale of gelatine and related products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
C.J. Gelatine Products Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹19.96 |
| 52 Week High | ₹26.72 |
| 52 Week Low | ₹16.45 |
| Beta | -0.0046 |
| 11 Month Change | -13.22% |
| 3 Month Change | -18.30% |
| 1 Year Change | -13.78% |
| 33 Year Change | 7.60% |
| 5 Year Change | 141.94% |
| Change since IPO | 18.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| 507515 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -7.1% | -1.9% | -1.2% |
| 1Y | -13.8% | 9.6% | 25.5% |
Return vs Industry: 507515 underperformed the Indian Chemicals industry which returned 11.8% over the past year.
Return vs Market: 507515 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 507515 volatility | |
|---|---|
| 507515 Average Weekly Movement | 7.0% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 507515 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 507515's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 80 | Jaspal Singh | www.cjgelatineproducts.com |
C.J. Gelatine Products Limited engages in the manufacture and sale of gelatine and related products in India. It offers pharmaceutical, edible, technical, and photographic gelatine products, as well as ossein and di-calcium phosphate products. C.J.
C.J. Gelatine Products Limited Fundamentals Summary
| 507515 fundamental statistics | |
|---|---|
| Market cap | ₹96.07m |
| Earnings (TTM) | -₹6.98m |
| Revenue (TTM) | ₹396.28m |
0.2x
P/S Ratio-13.8x
P/E RatioIs 507515 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 507515 income statement (TTM) | |
|---|---|
| Revenue | ₹396.28m |
| Cost of Revenue | ₹304.21m |
| Gross Profit | ₹92.07m |
| Other Expenses | ₹99.06m |
| Earnings | -₹6.98m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.45 |
| Gross Margin | 23.23% |
| Net Profit Margin | -1.76% |
| Debt/Equity Ratio | 468.2% |
How did 507515 perform over the long term?
See historical performance and comparison